Roche and Zealand’s Phase II obesity trial divides analyst opinion
Roche and Zealand Pharma’s co-developed amylin analogue, petrelintide, has met its primary endpoint in a Phase II trial, but the…
News
EMA posts draft guidance on running trials during public health emergencies
DiaMedica gains Health Canada approval for Phase II preeclampsia trial
Seqster unveils 1-Click DataLake for clinical trials
NHS awarded £47.8m to upgrade equipment to improve clinical trials
MIRA Pharmaceuticals completes dosing in Ketamir-2 Phase I trial
Clinical Trials Arena’s parent company GlobalData moves to Main Market of LSE
HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours
